DR. KYE SOO PARK MD NPI 1043359037

NPI Details

DR. Kye Soo Park, MD is a rheumatology internal medicine in Vancouver, WA with 22 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Kye Soo Park, MD NPI is 1043359037. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2004

The provider's business location address is:

700 NE 87TH AVE
VANCOUVER, WA
ZIP 98664-913
Phone: (360) 397-3370
Fax: (360) 604-1749

The NPI 1043359037 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)

The enumeration date for this NPI number is 2/6/2007 and was last updated on 9/22/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.